Free versus total ligand-binding assays: points to consider in biotherapeutic drug development

It is therefore very helpful for end users of bioanalytical data such as pharmacokinetic scientists and toxicologists to work together with bioanalytical scientists to assess the needs, technical feasibility and challenges of developing suitable bioanalytical assays in order to form a sound bioanalytical strategy.